Cubist Systematic Strategies, LLC P Lx Pharma Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.9 - $4.18 $23,313 - $51,288	-12,270 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.54 - $8.3 $188,823 - $442,722	-53,340 Reduced 81.3%	12,270 $50,000
Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $205,307 - $524,882	26,698 Added 68.61%	65,610 $526,000
Q3 2021 Nov 15, 2021	BUY	$12.22 - $21.28 $475,504 - $828,047	38,912 New	38,912 $751,000
Q2 2021 Aug 16, 2021	SELL	$9.0 - $15.94 $173,097 - $306,574	-19,233 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.24 - $10.14 $100,780 - $195,022	19,233 New	19,233 $174,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.